Cargando…

An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole

The purpose of this study was to evaluate efficacy and safety of voriconazole in patients with acute invasive aspergillosis (IA) in a real-life, clinical setting. This was a multicenter observational study in adult patients treated with voriconazole for invasive mycosis. The study evaluated clinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jacobs, F., Selleslag, D., Aoun, M., Sonet, A., Gadisseur, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346940/ https://www.ncbi.nlm.nih.gov/pubmed/21971820 http://dx.doi.org/10.1007/s10096-011-1425-5

Ejemplares similares

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Safety, Efficacy, and Exposure–Response of Voriconazole in Pediatric Patients With Invasive Aspergillosis, Invasive Candidiasis or Esophageal Candidiasis
por: Martin, Judith M., et al.
Publicado: (2017)

Voriconazole: Lack of efficacy during treatment of invasive pulmonary aspergillosis: 2 case reports
Publicado: (2021)

Pharmacology and metabolism of voriconazole and posaconazole in the treatment of invasive aspergillosis-review of the literature
por: Sandherr, M, et al.
Publicado: (2011)

Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin - review of the literature
por: Karthaus, M
Publicado: (2011)

Economic considerations in the treatment of invasive aspergillosis: a review of voriconazole pharmacoeconomic studies
por: Krueger, Kem P, et al.
Publicado: (2009)

Orbital Aspergillosis: Voriconazole – The New Standard Treatment?
por: Ohlstein, Derek H., et al.
Publicado: (2012)

Management of invasive aspergillosis in patients with COPD: Rational use of voriconazole
por: Ader, Florence, et al.
Publicado: (2009)

Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in Spain
por: Grau, Santiago, et al.
Publicado: (2016)

Cost-Effectiveness Analysis of Isavuconazole vs. Voriconazole as First-Line Treatment for Invasive Aspergillosis
por: Harrington, Rachel, et al.
Publicado: (2016)

Dexamethasone/voriconazole: Invasive aspergillosis following off-label use; lack of efficacy: case report
Publicado: (2022)

Cost-effectiveness analysis of isavuconazole versus voriconazole for the treatment of patients with possible invasive aspergillosis in Sweden
por: Floros, Lefteris, et al.
Publicado: (2019)

Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis
por: Maertens, Johan A., et al.
Publicado: (2023)

Dexamethasone/voriconazole: Invasive pulmonary aspergillosis secondary to Aspergillus terreus and treatment failure: case report
Publicado: (2021)

Efficacy of the Combination of Voriconazole and Caspofungin in Experimental Pulmonary Aspergillosis by Different Aspergillus Species
por: Zhang, Ming, et al.
Publicado: (2013)

Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Therapeutic Drug Monitoring of Sputum Voriconazole in Pulmonary Aspergillosis
por: Sarfati, Sacha, et al.
Publicado: (2022)

Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial
por: Cadranel, J., et al.
Publicado: (2012)

Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study
por: Kim, Sun Bean, et al.
Publicado: (2017)

358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)
por: Cheng, Matthew P, et al.
Publicado: (2018)

1169. In Vitro Activity of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults Enrolled in a Clinical Trial
por: Castanheira, Mariana, et al.
Publicado: (2020)

Invasive maxillary sinus aspergillosis: A case report successfully treated with voriconazole and surgical debridement
por: Peral-Cagigal, Beatriz, et al.
Publicado: (2014)

Posaconazole achieves prompt recovery of voriconazole-induced liver injury in a case of invasive aspergillosis
por: Martínez-Casanova, Javier, et al.
Publicado: (2018)

1147. Short Course of Voriconazole Therapy as a Risk Factor for Relapse of Invasive Pulmonary Aspergillosis
por: Shin, Dong Hoon, et al.
Publicado: (2020)

Immunosuppressants/voriconazole: COVID-19 infection, invasive systemic aspergillosis and visual disturbance: case report
Publicado: (2021)

Poststernotomy aspergillosis: successful treatment with voriconazole, surgical debridement and vacuum-assisted closure therapy
por: Siciliano, Rinaldo Focaccia, et al.
Publicado: (2012)

1211 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Invasive Aspergillosis Patients
por: Kontoyiannis, Dimitrios, et al.
Publicado: (2014)

Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials
por: Andes, David R., et al.
Publicado: (2018)

The pharmacokinetic challenge of voriconazole therapy for cerebral aspergillosis in patients treated with ibrutinib
por: Nyga, Rémy, et al.
Publicado: (2019)

Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report
Publicado: (2021)

1210 A Phase 3, Randomized, Double-Blind, Non-inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole versus Voriconazole in Patients with Invasive Mold Disease (SECURE): Outcomes in Neutropenic Patients
por: Patterson, Thomas, et al.
Publicado: (2014)

Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis
por: Chai, Louis Yi Ann, et al.
Publicado: (2014)

Tolerability of oral itraconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A systematic review and meta-analysis
por: Olum, Ronald, et al.
Publicado: (2020)

825 A Phase 3, Randomized, Double-Blind, Non-Inferiority Trial to Evaluate Efficacy and Safety of Isavuconazole vs Voriconazole in Patients with Invasive Mold Disease (IMD): Outcomes in Patients with Pulmonary Infections
por: Raad, Issam, et al.
Publicado: (2014)

A suspected case of autoinduction of voriconazole metabolism in a patient with cerebral aspergillosis
por: Ferguson, Martin J, et al.
Publicado: (2017)

Voriconazole-Induced Hepatotoxicity in a Patient with Pulmonary Aspergillosis: A Case Report
por: Gu, Li, et al.
Publicado: (2023)

Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/voriconazole: Invasive pulmonary aspergillosis, off label use and lack of efficacy: case report
Publicado: (2021)

Isavuconazole for the treatment of invasive aspergillosis and mucormycosis: current evidence, safety, efficacy, and clinical recommendations
por: Natesan, Suganthini Krishnan, et al.
Publicado: (2016)

PB2589: EFFICACY AND SAFETY OF ABCD IN THE TREATMENT OF INVASIVE ASPERGILLOSIS IN PATIENTS WITH HEMATOLOGIC DISEASES
por: Pang, Aiming, et al.
Publicado: (2023)

Treatment of invasive fungal infections in clinical practice: a multi-centre survey on customary dosing, treatment indications, efficacy and safety of voriconazole
por: Vehreschild, Jörg J., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_bbprsd0epms0bhkts5ju7p08em